Afmd stock nasdaq
Do Options Traders Know Something About Affimed (AFMD) Stock We Don't? 12-24 zacks.com - 1 Investors in Affimed N.V. (AFMD - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 18, 2019 $5.00 Put had some of the highest implied volatility of all equity options today. Find real-time AFMD - Affimed NV stock quotes, company profile, news and forecasts from CNN Business. 8/30/2018 · With a heavyweight partner, an extended operational runway, valuable wholly-owned assets and near-term material events, the stock remains attractive as both a catalyst and a revaluation idea. Shares of German biotech Affimed Therapeutics (NASDAQ: AFMD ) have risen by around 220% since my February article came out stating that data would finally trump poor execution in 2018. Technical stock forecast for AFMD: Affimed N.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level
Common Stock filings: AFMD of note. Mixed Shelf Offerings filed: LXRX ADMS DRNA of note. Convertible Offering Files: None of note.Kevin Bidenkap (@BidenkapKevin) | Twitterhttps://twitter.com/bidenkapkevinNejnovější tweety od uživatele Kevin Bidenkap (@BidenkapKevin): "U.S. Proposes Duties on $2.4 Billion of French Goods Over Tech Tax #internationaltrade #tariffs #foreignrelations #technolgy #frenchwine #digitaltax https://t.co/Ulrxfmc7Hk"
Nasdaq: AFMD (Affimed N.V.) has closed at $2.49, its traded Volume was 1012.7K shares, AFMD opened the Day at $2.28, it made an intraday Low of $2.28, and an intraday High of $2.4999. Get today's Cassava Sciences Inc stock price and latest SAVA news as well as Cassava Sciences real-time stock quotes, technical analysis, full financials and more. Munich/Amsterdam, 15 September 2014. It is with great pleasure that today, LSP – the specialist European healthcare investment firm – announces that its portfolio company Affimed was successfully listed on the Nasdaq stock exchange on… The Therapy Acceleration Program research grant funds projects developing innovative blood cancer treatments, supportive care and diagnostics. U.S. stocks are relatively flat ahead of the open, after selling off yesterday.Here are some small cap stocks traders are watching ahead of the bell Phoenix Biotechnology, Inc. (“Phoenix” or the “Company” www.phoenixbiotechnology.com) today announced that it has completed the private placement of 1,373,400 shares of common stock for gross proceeds of $4,120,200.
Affirmed Therapeutics B.V. (NASDAQ: AFMD) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance
Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities.
Affimed N.V. stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Affimed N.V. (AFMD) Reports Q3 Loss, Misses Revenue Estimates Affimed N.V. (AFMD) delivered earnings and revenue surprises of -35.71% and -65.47%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? Affimed N.V. (AFMD) News – Find the latest company news headlines for Affimed N.V. and all the companies you research at NASDAQ.com
Affimed N.V. (Nasdaq: AFMD) is a clinical-stage biopharmaceutical company, focused on cancer immunotherapies. Its lead candidate is AFM13, a natural killer cell (NK-cell) TandAb, which is in a Phase 2a clinical study.
26 Dec 2019 Affimed NV (NASDAQ:AFMD) was up 1.4% on Tuesday . The stock traded as high as $2.99 and last traded at $2.98, approximately 27870 The Nasdaq Stock Market, /ˈnæzˌdæk/ ( About this sound listen) also known as Nasdaq, is an American stock exchange located at One Liberty Plaza in New 6 Dec 2019 Affimed N.V. (AFMD). traded with down change of -0.86% at $2.31 on close of Thursday trading day. This stock price move and price 9 Dec 2019 On Friday, December 06, 2019, by making a change of -1.3% with the Loss (↓), the Healthcare stock (Affimed N.V.) created a change of 28 Aug 2019 Click here to be notified of future articles like this · or set a free stock price alert for your favorite stocks. You can read the full RBD archive by 10 Dec 2019 On Monday, December 09, 2019, Affimed N.V., (NASDAQ: AFMD) recorded at AFMD stock price revealed pessimistic move of -28.34 percent
Nasdaq: AFMD (Affimed N.V.) has closed at $2.49, its traded Volume was 1012.7K shares, AFMD opened the Day at $2.28, it made an intraday Low of $2.28, and an intraday High of $2.4999. Get today's Cassava Sciences Inc stock price and latest SAVA news as well as Cassava Sciences real-time stock quotes, technical analysis, full financials and more. Munich/Amsterdam, 15 September 2014. It is with great pleasure that today, LSP – the specialist European healthcare investment firm – announces that its portfolio company Affimed was successfully listed on the Nasdaq stock exchange on…